EUVIMEDEUVIMED entdecken
VergleichsstudieNetzwerk-Metaanalyse

Anti‐ VEGF monotherapy versus anti‐ VEGF therapy combined with laser or intravitreal glucocorticoid therapy for diabetic macular edema: A Bayesian network meta‐analysis

Xiaofei Yang, Yang Cao, Xiaoming Cao, Lijuan Wang, Xiaoxia Zhang, Zengyu Zhang, Xinyu Zai, Zheyi Yan iD

Diabetes, Obesity and Metabolism · 2025

DOI: 10.1111/dom.16270 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Diabetes, Obesity and Metabolism, 2025. Verfasst von Xiaofei Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical College, Shanxi Medical University, Taiyuan, China. Hauptthemen laut MEDLINE: Angiogenesis Inhibitors, Diabetic Retinopathy, Glucocorticoids, Laser Therapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Program of Shanxi Province, Fund Program for the Scientific Activities of Selected Returned Overseas Professionals in Shanxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To conduct a network meta‐analysis (NMA) comparing the efficacy of anti‐vascular endothelial growth factor (VEGF) monotherapy versus anti‐VEGF therapy combined with laser or intravitreal glucocorticoid therapy for diabetic macular edema (DME). Materials and Methods PubMed, Embase, and the Cochrane Library were systematically searched for randomized controlled trials comparing anti‐VEGF monotherapy with anti‐VEGF therapy combined with laser or intravitreal glucocorticoid therapy for DME. The primary outcomes included the mean best‐corrected visual acuity (BCVA) and central macular thickness (CMT) changes from the baseline. A NMA for continuous outcomes was conducted using a fixed‐effects model, with mean difference (MD) and corresponding 95% credible interval (CI) reported.

Results

The NMA included 21 randomized controlled trials involving 1798 eyes. Anti‐VEGF monotherapy and anti‐VEGF combined with laser or intravitreal glucocorticoid therapy did not significantly change the mean CMT and BCVA at 6 and 12 months from the baseline. Simulation‐based ranking results for mean BCVA changes suggested that anti‐VEGF therapy combined with laser therapy was likely the most effective at 6 (70.7515%) and 12 (70.9315%) months. Similar results were observed in the simulation‐based ranking of mean CMT changes, suggesting that anti‐VEGF therapy combined with laser therapy was likely the most effective at 6 (83.6350%) and 12 (74.7730%) months.

Conclusions

Anti‐VEGF monotherapy and anti‐VEGF therapy combined with laser or intravitreal glucocorticoid therapy exerted comparable effects. However, the ranking chart recommends anti‐VEGF therapy combined with laser therapy. Meanwhile, anti‐VEGF therapy combined with intravitreal glucocorticoid therapy did not demonstrate significant benefits.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angiogenesis InhibitorsDiabetic RetinopathyGlucocorticoidsLaser TherapyMacular EdemaVascular Endothelial Growth Factor AHumansBayes TheoremCombined Modality TherapyIntravitreal InjectionsRandomized Controlled Trials as TopicRanibizumabTreatment OutcomeVisual Acuity

Stichwörter der Autor:innen

anti‐VEGFdiabetic macular edemaintravitreal glucocorticoidlasernetwork meta‐analysis

Substanzen

Angiogenesis InhibitorsGlucocorticoidsRanibizumabVascular Endothelial Growth Factor AVEGFA protein, human

Autor:innen und Institutionen

  • The First Clinical Medical College, Shanxi Medical University, Taiyuan, China.
  • Department of Ophthalmology, First Hospital of Shanxi Medical University, Taiyuan, China.
  • Department of Orthopedics, Shanxi Medical University Second Affiliated Hospital, Taiyuan, China.

ORCID-Profile: Zheyi Yan

Förderung

  • National Natural Science Foundation of China
  • Fundamental Research Program of Shanxi Province
  • Fund Program for the Scientific Activities of Selected Returned Overseas Professionals in Shanxi Province

Zitieren

APA

Yang, X., Cao, Y., Cao, X., Wang, L., Zhang, X., Zhang, Z., Zai, X., & Yan, Z. (2025). Anti‐ VEGF monotherapy versus anti‐ VEGF therapy combined with laser or intravitreal glucocorticoid therapy for diabetic macular edema: A Bayesian network meta‐analysis. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.16270

Vancouver

Yang X, Cao Y, Cao X, Wang L, Zhang X, Zhang Z, et al. Anti‐ VEGF monotherapy versus anti‐ VEGF therapy combined with laser or intravitreal glucocorticoid therapy for diabetic macular edema: A Bayesian network meta‐analysis. Diabetes, Obesity and Metabolism. 2025. doi:10.1111/dom.16270

BibTeX
@article{Yang2025,
  author = {Yang, Xiaofei and Cao, Yang and Cao, Xiaoming and Wang, Lijuan and Zhang, Xiaoxia and Zhang, Zengyu and Zai, Xinyu and Yan, Zheyi},
  title = {Anti‐ VEGF monotherapy versus anti‐ VEGF therapy combined with laser or intravitreal glucocorticoid therapy for diabetic macular edema: A Bayesian network meta‐analysis},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2025},
  doi = {10.1111/dom.16270}
}
Kostenlos starten →